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The role of pro-inﬂammatory cytokines in psychiatric disorders has been the focus of great research attention in recent years. Para-
doxically, the same is not true for anti-inﬂammatory cytokines. In the present study, we assessed the behavioral proﬁle of animals with
altered expression of the anti-inﬂammatory cytokine IL-10.
We performed a battery of tests to assess anxiety, depressive-like and cognitive behaviors in mice overexpressing IL-10 (PMT10) and
IL-10/ animals; in the later mice we also tested the behavioral eﬀect of IL-10 administration.
In the forced-swimming test, IL-10/ females displayed increased depressive-like behavior; importantly, this phenotype was reverted
by the injection of IL-10. Moreover, mice overexpressing IL-10 presented a decreased depressive-like behavior. Despite the presence of a
similar trend, male animals did not reach signiﬁcant diﬀerences in depressive-like behavior. Assessment in the open-ﬁeld showed that the
absence of IL-10 decreased the percentage of time spent in the center of the arena in both male and female mice, while male animals
overexpressing IL-10 revealed an opposite behavior. For both sexes, imbalance in IL-10 levels did not aﬀect spatial reference memory.
In conclusion, variations in IL-10 expression are associated with an altered depressive-like behavior, but do not inﬂuence cognitive
performance. Interestingly, IL-10 imbalance produced more profound behavioral changes in females than in male animals. This is in
accordance with clinical data demonstrating an increased susceptibility of women to mood disorders, suggesting an interplay between
anti-inﬂammatory cytokines and sexual steroids.
 2008 Published by Elsevier Ltd.













The cross-talk between the central nervous system
(CNS) and the peripheral immune system has been a sub-
ject of great research interest in recent years. Since the dis-
covery of cytokine receptors in both glial cells and neurons
(Araujo et al., 1989; Breder et al., 1988; Cunningham and
De Souza, 1993; McGeer and McGeer, 1995). The inﬂu-
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(2008), doi:10.1016/j.jpsychires.2008.02.004signaling by cytokines produced peripherally or within
the CNS (mainly by microglia and astrocytes) (Araujo
et al., 1989; Breder et al., 1988; Cunningham and De
Souza, 1993; McGeer and McGeer, 1995), has been char-
acterized. Several studies have highlighted the role of cyto-
kines in neuropathogenesis, particularly in mood disorders
(Papanicolaou et al., 1998; Schiepers et al., 2005; Yirmiya
et al., 2000). Indeed, one of the most consistent observa-
tions in the ﬁeld is the increased levels of pro-inﬂammatory
cytokines in depression (Lanquillon et al., 2000; Maes
et al., 1995b; Mikova et al., 2001; Sluzewska et al., 1995;
Tuglu et al., 2003).
In an attempt to integrate the above described ﬁndings, it
has been proposed that the release of pro-inﬂammatory















































































































2 A.R. Mesquita et al. / Journal of Psychiatric Research xxx (2008) xxx–xxx
PIAT 1123 No. of Pages 9, Model 5+









determinant for the behavioral, neuroendocrine and neuro-
chemistry alterations associated with depressive disorders
(Maes et al., 1993). Whether these changes in cytokine
expression are the cause or consequence of depression is still
a matter of dispute, but the demonstration that the immune
dysregulation precedes the development of depression (Yir-
miya et al., 2000) is of notice. In support of the role of cyto-
kines in mood disorders are the observations of early
depressive symptoms in patients receiving interferon and
IL-2 therapy (Capuron et al., 2000); interestingly, subse-
quent studies have also shown that these depressive
symptoms can be relieved by the administration of antide-
pressants (Musselman et al., 2001; Yirmiya et al., 2001).
The role of cytokines in mood disorders is further strength-
ened by the demonstration that pro-inﬂammatory cytokines
are able to activate the hypothalamus–pituitary–adrenal
(HPA) axis (Crane et al., 2003). The overactivation of the
HPA is one of the most recognized ﬁndings in mood disor-
ders and considered to be an important trigger of these psy-
chopathologies (Carroll et al., 1968; Plotsky et al., 1998).
Moreover, increases in both IL-1b (Linthorst et al., 1995;
Merali et al., 1997; Shintani et al., 1993; Song et al., 1999)
andTNF (Brebner et al., 2000;Hayley et al., 1999) have been
associated with alterations at the neurochemical level, pre-
dominantly in the serotoninergic system (Dunn et al.,
1999), in several brain regions known to be implicated in
depression. As a consequence, animals exposed to increase
levels of pro-inﬂammatory cytokines display signs of depres-
sive-like behavior (De La Garza, 2005; Dunn et al., 2005)
and increased anxiety (Silverman et al., 2007).
While several reports implicate pro-inﬂammatory cyto-
kines in behavior, less is known on the inﬂuence of anti-
inﬂammatory cytokines. Among the few studies on the sub-
ject, administration of IL-10 prior to LPS injection has
been shown to revert the behavioral eﬀects of LPS injection
(Bluthe et al., 1999), including the eﬀects upon mobility,
rearing activity and social exploration and interaction
(Leon et al., 1999; Nava et al., 1997; Smith et al., 1999).
Several authors have hypothesized that the behavioral
eﬀects of IL-10 are a consequence of an inhibitory eﬀect
on IL-1, INF-c and TNF production and not a direct eﬀect
of this anti-inﬂammatory molecule; in fact, it is known that
IL-10 is important on the down-modulation of these pro-
inﬂammatory cytokines (Fiorentino et al., 1991; Harvey
et al., 2006; Moore et al., 2001). However, more recently,
it was demonstrated that IL-10 administration to animals
without exposure to inﬂammatory challenge induces
increased motor activity and abnormal exploratory pat-
terns (Harvey et al., 2006), which indicates that this cyto-
kine might directly inﬂuence behavior. In this study, we
aimed to further investigate whether manipulation of IL-
10 levels could modulate behavior. To achieve this goal,
we examined the behavioral proﬁle of IL-10/ and trans-
genic mice that overexpress this anti-inﬂammatory cyto-
kine (PMT10); moreover, to further assess the inﬂuence
of this cytokine in modulating behavior, we analyzed the








2. Methods and materials
2.1. Animals
The IL-10/ animals on a Balb/c background were
bred in our animals facilities from a breeding pair provided
from Dr. A. O’Garra (National Institute for Medical
Research, London, UK). For behavioral characterization
of these knock-out animals, we used 40 IL-10/ (23
females and 17 males) on a Balb/c background and 31
wild-type Balb/c (17 females and 14 males) as respective
controls. All animals were genotyped by PCR. As some
IL-10/ animals develop spontaneous inﬂammatory
bowel disease, analysis of bowels was carefully performed
throughout the experimental period and diarrheic animals
were excluded from this study.
PMT10 animals on a C57BL/6 background were pro-
duced by Drs. P Vieira and AG Castro. A mouse IL-10
cDNA sequence was cloned in the p169ZT vector (Sousa
et al., 2002), which carries the sheep metallothioneinc
(MT) Ia promoter (Peterson and Mercer, 1986), a b-globin
splice site and the SV40 polyadenylation signal. The result-
ing vector (pMT-IL10) was injected in C57BL/6 eggs and
transgenic founders were identiﬁed by PCR using MT-spe-
ciﬁc primers. The presence of the transgene was conﬁrmed
by Southern blot analysis encompassing the sheep MT-pro-
moter. PMT10 mice were bred at our animal facilities. In
this experiment, ten PMT10 animals and ten wild-type
C57BL/6 as respective controls were used. IL-10 overex-
pression was induced by giving a 2% sucrose solution with
50 mM of zinc sulfate to animals ad libitum. As the IL-10
promoter is associated with a metalloprotein, the presence
of zinc in this solution induces its activation. Wild type ani-
mals were also supplied with the same drinking solution.
Serum levels of IL-10, which range between 3 and 5 ng/
ml, could be measured 3 days after induction and remained
stable while the animals were drinking the zinc solution.
IL-10 was never detected in the serum of non-transgenic lit-
termates or in non-induced transgenic mice. IL-10 overex-
pression was induced 1 week before the behavioral testes
were initiated.
All mice were kept in an animal facility in a 12 h
light:12 h dark cycle, with food and water available ad libi-
tum. Males and females were kept separately. At 3 months
of age all animals were behaviorally tested between 10 a.m.
and 5 p.m. in a counterbalanced order; IL-10/ mice were
compared to wild-type Balb/c, whereas PMT10 animals
were compared to wild-type C57BL/6 mice. At the end of
the experiment, animals were sacriﬁced by decapitation;
decapitation was performed by trained operators. All exper-
imental procedures were conducted in accordance to the
European Communities Council Directive, 86/609/EEC.
2.2. IL-10 injection
Another subset of 20 females and 16 males of IL-10/
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systems, Minneapolis, USA). Half of these animals
received a daily i.p. injection of 40 ng of IL-10 for 11 days
(6 days prior the behavioral analysis followed by 5 more
days concomitant with the behavioral assessment), while













Serum levels of INF-c were measured by a two-side
sandwich ELISA with the anti-IFN-c speciﬁc aﬃnity-puri-
ﬁed mAbs (R4-6A2 as capture and biotinylated AN-18 as
detecting mAbs), and a standard curve was generated with
known amounts of IFN-c (Peprotech, Rocky Hill, NJ,
USA). The sensitivity of the assay was 16 pg/ml.
Quantiﬁcation of TNF-a was done by ELISA (Duo Set;
R&D Systems, Minneapolis, USA). The sensitivity of the
assay was 32 pg/ml.
Serum levels of IL-10 were determined by ELISA
(Quantikine; R&D Systems, Minneapolis, USA). The sen-















Animals were placed in the center of the arena
(43.2  43.2 cm transparent acrylic walls and white ﬂoor)
and their position was monitored and recorded by a two
16-beam infrared system (MedAssociates, Vermont,
USA), over a period of 5 min. Time in the predeﬁned cen-
tral and peripheral areas was recorded and used to evaluate
anxious-like behavior, while the total distance traveled
assessed spontaneous activity. The number and duration
of the ‘‘rearings” (vertical activity) were also recorded as
a measure of exploratory behavior. RC
O
R2.4.2. Elevated-plus mazeAnimals were placed in a elevated-plus maze (EPM)
apparatus consisting of two opposite open arms
(50.8  10.2 cm) and two opposite closed arms
(50.8  10.2  40.6 cm) raised 72.4 cm above the ﬂoor
(ENV-560, MedAssociates, Vermont, USA). The number
of entries and the time spent in each arm was registered
by an infrared system over a total test period of 5 min.Fig. 1. Thymus and adrenal glands weight relative to the body weight of
Wild-type and IL10/ females and males (A and B) and IL-10/
receiving IL-10 (IL-10/ + IL-10) and IL-10/ receiving saline (IL-10/
 + Saline) animals (C and D). Values are means ± SE and *p < 0.05.U
N
2.4.3. Forced-swimming test
Animals were placed in a cylinder (diameter: 37 cm;
55 cm of height) ﬁlled with water (25 C) to 35 cm depth
such as that they had no solid support for the rear paws
nor for the tail. Animals were tested in a 5 min session
24 h after being exposed to the test for the same time per-
iod. Only the second session was recorded and later scored
by two independent researchers which were blind to the
experimental conditions. Time of immobility and latency
to immobility were computed and used as a measure of








2.4.4. Morris water maze
This maze consisted of a tank (diameter: 170 cm; depth:
50 cm), divided into quadrants by imaginary lines and ﬁlled
with opaque water to a depth of 31 cm. During testing, a
platform (12  12 cm; invisible to the mice) was placed in
the same quadrant during ﬁve consecutive days. Each test
session consisted of four trials which lasted in maximum
for 2 min. Time spent swimming to reach the hidden plat-
form was recorded and used to evaluate learning and mem-
ory performances.
2.5. Statistical analysis
All the results from the behavioral tests are expressed as
mean ± standard error of the mean (SEM). Statistical anal-
yses were performed using SPSS 15.0 software (SPSS Inc.,
Chicago/IL). The eﬀect of gender and IL-10 expression, per
se, in theOpenField and the forced swimming testswere ana-
lyzed by independent samples t-test, while the overall eﬀects
were studied by two-way analysis of variance (ANOVA).
Data from theMorriswatermaze taskwas analyzed using
a repeated measures ANOVA analysis throughout the 5
days test. Each day is a mean of the four consecutive trials.
All behavioral results are expressed as means ± SE and sta-
tistical signiﬁcance was considered for p values 60.05.
3. Results
3.1. Biometric parameters
Analysis of the relative weight of thymus and adrenal
glands from IL-10/ animals compared with wild-type
animals showed a signiﬁcant reduction of the thymus in
both male and female mice (t = 3.9; p 6 0.001 and




















































































Fig. 2. Depressive-like behavior assessed with the forced-swimming test
(FST). IL-10/ females displayed increased immobility time and decrease
latency to immobility compared with their wild-type controls (A). No
signiﬁcant eﬀect was observed in male mice (B). Administration of IL-10
was only able to increase activity time in female IL-10/ mice, when
compared with IL-10/ mice receiving saline injection (C and D). Female
animals overexpressing IL-10 (PMT10) revealed an increase activity time
in the FST (E). The same tendency was obtained for male PMT10 animals
(F). Values are means ± SE and *p < 0.05.
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ANOVA revealed a gender eﬀect on adrenals weight
(F1,27 = 24.1; p < 0.001), with interaction between gender
and IL-10 factors. Interestingly, IL-10 administration
reverted the atrophy of thymus in IL-10/ mice
(t = 3.1; p < 0.05 for females and t = 3.5; p < 0.05 for
males) (Fig. 1C and D).
Regarding the adrenals weight, a signiﬁcant increase was
found in females IL-10/ (t = 4.5; p < 0.001) (Fig. 1A).
Once more, IL-10 administration showed to be eﬀective
in restoring the adrenals weight in IL-10/ females
(t = 2.5; p < 0.05; Fig. 1C). No statistical signiﬁcance was
found in males (Fig. 1B and D). Two-way ANOVA
showed a gender eﬀect on both biometric parameters
(F1,31 = 13.8; p < 0.05 for thymus and F1,31 = 9.3;
p < 0.05 for adrenal glands).
3.2. IL-10 production inﬂuences depressive-like behavior in
female mice
In the forced-swimming test (FST) we evaluated the abil-
ity of mice to cope with a stressful and inescapable situation
(learned helplessness). In this test, animals displaying
decreased latency to immobility and longer immobilization
periods are considered to have increased helplessness, which
is a sign of depressive-like behavior. When tested in the
FST, IL-10/ female showed decreased activity (t = 6.1,
p < 0.001) during the 5 min of the test and stopped swim-
ming earlier than wild-type mice (t = 3.3 p < 0.005
(Fig. 2A). No signiﬁcant diﬀerences were observed between
male animals (Fig. 2B). Two-way ANOVA revealed a sig-
niﬁcant eﬀect of gender, being the females more aﬀected
than males in latency to immobility (F1,67 = 14.0,
p 6 0.001) and activity times (F1,67 = 5.2, p 6 0.05).
Interestingly, IL-10 administration was able to reverse
the depressive-like phenotype of IL-10/ females, in as
much as after administration of this cytokine there was an
increased activity time namely when compared with animals
receiving saline injection (t = 2.9, p < 0.05) (Fig. 2C).
Although this diﬀerence was only observed in females, a
similar trend was also found in male mice (Fig. 2D).
Further supporting the anti-depressant action of IL-10,
PMT10 female mice showed increased activity time when
compared with their respective counterparts (t = 5.5;
p 6 0.001), which reveals a decreased susceptibility to
depressive-like behavior (Fig. 2E). Although male animals
showed a similar behavioral pattern, no statistical signiﬁ-
cant diﬀerences were observed in any of the parameters
analyzed (Fig. 2F). Again, two-way ANOVA showed a sig-
niﬁcant eﬀect of gender in the activity time (F1,16 = 6.5,
p 6 0.05), being the females more vulnerable to IL-10
imbalances.
3.3. Variations in IL-10 levels aﬀect anxious-like behavior in
the open-ﬁeld
The open-ﬁeld test (OF) was performed to assess general
locomotor activity and exploratory behavior. In terms ofPlease cite this article in press as: Mesquita AR et al., IL-10 modu
(2008), doi:10.1016/j.jpsychires.2008.02.004spontaneous activity, assessed by the total distance traveled
throughout the 5 min of the test, no diﬀerences were
observed between IL-10/ and wild-type animals. More-
over, both IL-10 administration and overexpression failed
to induce any change in this behavior both in males and
females.
Analysis of the exploratory behavior in terms of ani-
mals’ vertical activity (number and duration of rearings)
revealed a signiﬁcant increase in both measurements in
IL-10/ female mice compared to their wild-type counter-
parts (Fig. 3A). No signiﬁcant diﬀerences were observed in
male animals, although there was a trend for increased
exploratory behavior in IL-10/ animals (Fig. 3B). Both
the administration and the overexpression of IL-10 failed
to show any eﬀect in vertical activity (Fig. 3C, D and E,
F), despite a tendency for reduction after IL-10 administra-
tion in male IL-10/ mice.
Although the OF is not the most widely used test to
assess anxious-like behavior, the percentage of time spent
in center of the arena over the total time provides an indic-
ative measure of anxiety-behavior (Boguszewski and Zag-






















































Fig. 3. Vertical activity assessed by the number and duration of rearings
in the open-ﬁeld test (OF), showed increased exploratory behavior in IL-
10/ female but not in males (A and B); IL-10 administration did not
change rearing activity neither in male or female mice (C and D). No
signiﬁcant diﬀerences in rearing activity were observed between PMT10
and respective control animals (E and F). Values are means ± SE and
*p < 0.05.
Fig. 4. Anxious-like behavior assessed by the time spent in the center of
the OF arena, showed increased anxiety in IL-10/ (A and B). However,
administration of IL-10 only reversed the phenotype in IL-10/ male (C
and D). Male PMT10 spent more time in the center than control animals a
sign of decreased anxious-like behavior (E and F). Values are means of the
percentage of time spent in the center over the total time ± SE and
*p < 0.05.
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CAnalysis of this parameter demonstrated that both female
and male IL-10/ mice spent signiﬁcantly less time in
the center than in the periphery when compared to wild-
type animals (t = 2.6, p < 0.05, t = 4.0, p 6 0.001, respec-
tively) (Fig. 4A and B).
Interestingly, the IL-10 treatment was able to reverse the
IL-10/ mice phenotype, in males, resulting in increased
time spent in the center of the OF arena (t = 2.9,
p < 0.05). Two-way ANOVA revealed a gender eﬀect in
this parameter (F1,32 = 4.6, p < 0.05) (Fig. 4C and D).
The same trend was observed for PMT10 animals which
spent signiﬁcantly more time in the center of the OF, even
though diﬀerences were only signiﬁcant in males (t = 4.3,
p 6 0.05; Fig. 4E and F).
However, care must be taken in the interpretation of
these results as no diﬀerences were found in the EPM in
neither IL-10/ nor in PMT10 mice when compared with
respective control animals (data not shown).
3.4. IL-10 production did not aﬀect hippocampal-dependent
spatial memory
To investigate whether changes in IL-10 ‘‘milieu” inﬂu-
ence hippocampal-dependent learning and memory, the
Morris water maze (MWM) test was performed. No diﬀer-
ences were found in both male and females regarding thePlease cite this article in press as: Mesquita AR et al., IL-10 modu
(2008), doi:10.1016/j.jpsychires.2008.02.004time and the distance swam to ﬁnd the hidden platform
(Fig. 5), thus showing that neither the overexpression nor
the absence of IL-10 seem to aﬀect spatial memory.
3.5. Changes in IL-10 expression did not induce detectable
changes in TNF-a and IFN-c levels
In order to investigate whether genetic manipulation of
IL-10 expression inﬂuences the production of two relevant
pro-inﬂammatory cytokines, the serum levels of TNF-a
and INF-c were measured. No diﬀerences were observed
between PMT10 and IL-10/ and their respective wild-
type controls as determinations for both cytokines in the
serum were below the detection levels (16 pg/ml for TNF-
a and 32 pg/ml for INF-c).
4. Discussion
By studying emotional behavior in mice lacking or over-
expressing IL-10, we herein show that this anti-inﬂamma-
tory cytokine inﬂuences depressive-like behavior. Mice
lacking IL-10 displayed signs of depressive-like behavior,
assessed by immobilization time and latency to immobility,
when compared to their strain-matched wild-type counter-








































































Fig. 5. Spatial memory evaluation in the classical Morris water maze (MWM) paradigm failed to show any signiﬁcant diﬀerence between IL-10/ and
wild-type animals for both female (A) and male (B). The same results were observed for PMT10 animals (C and D). Values are expressed as means of the
four trials/day ± SE and *p < 0.05.
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cytokine displayed an opposite behavioral phenotype.
Remarkably, variation in IL-10 levels aﬀected more pro-
foundly females, which correlates with the recognized
higher susceptibility of women to depression. Taken
together, these results reveal, for the ﬁrst time, that this
anti-inﬂammatory cytokine is an important mediator in
depression.
This observation adds to the so-called ‘‘cytokine
hypothesis of depression”, that was built on the evidence
that pro-inﬂammatory cytokines have a trigger eﬀect on
the pathogenesis of depression (Maes et al., 1995a; Maes
et al., 1993). This eﬀect was proposed to be mediated by
neuroendocrine and neurotransmitter systems involved in
vulnerability to aﬀective disorders (Maes, 1999). In this
respect it has been demonstrated that IL-1b and TNF-a
stimulate the expression/release of corticotrophin-releasing
hormone (CRH) in the paraventricular nucleus (PVN) of
the hypothalamus (Hayley et al., 2001; Tilders and
Schmidt, 1998), the control center of the HPA axis and
alters the turnover of norepinephrine and serotonin (5-
HT) in the hypothalamus, amygdala, prefrontal cortex,
and hippocampus (Ando and Dunn, 1999; Brebner et al.,
2000; Dunn et al., 1999; Hayley et al., 1999). Further evi-
dence for the role of pro-inﬂammatory cytokines in depres-
sion was gathered from studies with TNF receptors
(TNFR) knock-out mice, in which it was shown that both
TNFR1/ and TNFR2/ mice were more active in the
FST than wild-type animals (Simen et al., 2006). Impor-
tantly, the mechanisms underpinning the behavioral
changes in these mice models are similar and include alter-
ations in neurotransmission in regions of the brain impli-
cated in emotional behavior. Of notice, is also the
evidence of the immunomodulatory eﬀects of antidepres-Please cite this article in press as: Mesquita AR et al., IL-10 modu
(2008), doi:10.1016/j.jpsychires.2008.02.004E
Dsants that act preferentially in the noradrenergic and sero-
toninergic system. Kubera and co-workers (Kubera et al.,
2001) demonstrated the ability of diﬀerent drugs to
decrease the levels of INF-c, while increasing the levels of
the anti-inﬂammatory cytokine IL-10. These data were also
corroborated by studies using other antidepressants in
stimulated human blood cells (Maes et al., 1999).
While the involvement of pro-inﬂammatory cytokines in
many aspects of depressive illness is now indisputable, we
clearly demonstrate in this study that anti-inﬂammatory
cytokines also inﬂuence emotional behavior in rodents.
Work from Bluthe and collaborators (Bluthe et al., 1999)
had already suggested that IL-10 administration could
abrogate the behavioral eﬀects of LPS injection in sickness
behavior in rats. It was postulated that IL-10 inhibits the
expression of pro-inﬂammatory cytokines (IL-1, INF-c
and TNF-a) produced in response to LPS and its behav-
ioral consequences, increasing the duration of social inter-
action. The present data reveals that variations in IL-10
expression inﬂuence mood behavior, even in the absence
of detectable variations in the serum levels of INF-c and
TNF-a. This fact, however, does not exclude the possibility
of an inhibition of pro-inﬂammatory cytokines secretion in
the CNS; in accordance, IL-10 deﬁcient mice have
increased brain levels of TNF-a and IL-6 (Agnello et al.,
2000).
Another relevant issue raised from our study is the
increased susceptibility to variations in IL-10 expression
in females. Of relevance is the fact that the same gender
eﬀect is observed in the clinical practice, where the
increased susceptibility to depression in women in condi-
tions of decrease estrogen secretion (e.g., premenstrual,
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well-known (Osterlund et al., 2005). This increased suscep-
tibility has been attributed to ﬂuctuations in estrogen secre-
tion. In fact, evidence derived from experimental and
clinical studies demonstrated an important role of
(decreased) estrogens in the pathogenesis of depression
but also in the production and bioactivity of a variety of
cytokines (Nordell et al., 2003; Suuronen et al., 2005).
Estrogens depletion increases the levels of pro-inﬂamma-
tory cytokines (Bismar et al., 1995), and studies using mur-
ine microglia cells showed that estrogens are able to
increase IL-10 levels (Dimayuga et al., 2005). Accordingly,
our results suggest that in animals that cannot express IL-
10, the possible protective eﬀects induced by estrogens are
lost since IL-10/ female mice displayed increased signs of
depressive-like behavior when compared with male ani-
mals. In contrast, the higher levels of IL-10 present in
PMT10 animals were probable bolstered by estrogens,
potentiating their protective eﬀects and anti-depressive
eﬀects in female mice. Moreover, clinical studies showed
that estrogens not only trigger antidepressant-like actions
(for review, see (Halbreich and Kahn, 2001)) but also
improve the therapeutic action of antidepressants (Soares
et al., 2001), specially of those acting in the serotoninergic
system(Chang and Chang, 1999; Estrada-Camarena et al.,
2006; Lu and Bethea, 2002). Besides the inﬂuence of estro-
gens, other sexual steroids, such as testosterone, might also
be implicated in the gender diﬀerence observed in depres-
sive-like behavior after IL-10 imbalances. In fact some
human and animal studies have shown that testosterone
increases IL-10 expression (Liva and Voskuhl, 2001; Mal-
kin et al., 2004) and reduces the expression of pro-inﬂam-
matory cytokines such as IL-1b, IL-6 and TNF-a
(D’Agostino et al., 1999). Taken together, these data high-
light a possible interaction between sexual steroids and
cytokines actions.
The association between anxiety and depressive disor-
ders is well-known, and there are several common factors
involved in both conditions (Cameron, 2006; Cameron
et al., 2004; Gulley and Nemeroﬀ, 1993). Therefore, the
exploration of anxiety-like signs in experimental models
inﬂuencing depressive-like behavior becomes relevant.
Interestingly, data from the open-ﬁeld test suggested that
IL-10/ animals display a hyperanxious phenotype both
in males and females. However, this phenotype could not
be conﬁrmed in the EPM, a more robust test to assess anx-
iety-like behavior. A possible explanation for these para-
doxical ﬁndings could be the increased exploratory
behavior evinced by IL-10/ animals. As the EPM is
based on the conﬂict between the innate exploratory behav-
ior and fear of height and exposed environments, it is likely
that the increased tendency for exploration in IL-10/
might be a confounding eﬀect in this behavioral paradigm
and blunt the hyperanxious phenotype. In further support
of this view are the ﬁndings of decreased anxiety evinced
by PMT10 mice. Further studies, using other behavioral
tests, are needed to better explore the inﬂuence of IL-10 lev-








condition (an approach currently under study in our
laboratory).
While the inﬂuence of IL-10 on anxiety behavior needs
further experimental work, the present data rule out any
inﬂuence of this anti-inﬂammatory cytokine in reference
memory. In fact, the hippocampus-dependent task used to
assess spatial reference memory failed to reveal diﬀerences
between the performance of both genetically modiﬁed mice
models and their respectivewild-type controls. Theseﬁndings
are of relevance, in the sense that they reveal the speciﬁcity of
the inﬂuence of IL-10 levels in aﬀective/mood conditions.
In conclusion, our behavioral data demonstrate that IL-
10, an anti-inﬂammatory cytokine, is an important mole-
cule in the modulation of depressive-like behavior. This
ﬁnding calls for a reappraisal of the ‘‘cytokine hypothesis
of depression”, in the sense that imbalances of both pro-
or anti-inﬂammatory cytokines might modulate mood
behavior. Furthermore, the present observations might be
of relevance in all those conditions (autoimmune, malig-
nant and infectious disease) associated to polymorphisms
of the IL-10 family gene clusters in which depression seems
to be more prevalent (Nery et al., 2007; van Boxel-Dezaire
et al., 1999; Zorzon et al., 2001).
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